We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Selcia Appoints Simon Saxby as CEO and Andreas Rummelt to its Board

News   Feb 24, 2011

 
Selcia Appoints Simon Saxby as CEO and Andreas Rummelt to its Board
 
 
Advertisement
 

RELATED ARTICLES

New Catalyst for Asymmetric Synthesis of Aziridine Aids Development of Novel Drugs

News

Researchers have been able to obtain aziridine-oxazolone compounds in high yields (99%) as well as high enantioselectivity or purity (98%) using a new catalyst.

READ MORE

Antisense Therapies Developed To Counter Multidrug-Resistant Bacteria

News

A team from the University of Colorado Boulder has created a drug development platform that can produce effective and highly specific peptide nucleic acid therapies for use against any bacteria within just one week.

READ MORE

Compound Found in Shrub Targets “Undruggable” Cancer Protein

News

A Purdue University chemist has discovered a way to synthesize a rare compound found in a shrub native to North America, to fight a previously "undruggable" cancer protein implicated in numerous cancer types.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE